Navigation Links
Pfizer Animal Health and NTRA Charities Team Up to Benefit the Barbaro Memorial Fund
Date:1/31/2008

Promotions Support Fund's Goal of Finding a Cure for Laminitis

NEW YORK, Jan. 31 /PRNewswire/ -- Pfizer Animal Health and the National Thoroughbred Racing Association (NTRA) have joined forces to help fund laminitis research through the NTRA Charities - Barbaro Memorial Fund. The partnership's aim is to increase awareness of the Fund across the horse industry and encourage further support of cutting edge research into laminitis prevention and treatment.

Owners, trainers and horse enthusiasts alike can contribute directly to the work of the Barbaro Memorial Fund online at RidingwithBarbaro.org. Information on the donation site, and the Fund's goal, will be featured in 2008 Pfizer Animal Health advertising for several equine products, as well as on displays in select retail outlets across the country and at major equine events. Riding with Barbaro awareness bracelets will be available as part of select display promotions.

"Laminitis is a potentially devastating disease that affects horses at all levels of equine sports and across disciplines -- from great Thoroughbred champions like Barbaro, right on to recreational horses loved by their riders and owners," said Kristin Ruff, marketing manager, U.S. equine business, at Pfizer Animal Health. "We wanted to help raise awareness of the Fund's mission and encourage all kinds of horse people to donate what they can toward finding a cure."

"Pfizer's generous contribution and commitment to promote the NTRA Charities - Barbaro Memorial Fund will help further his legacy, both as a courageous and gifted racehorse and as the inspiration for promising new research on equine health," said Alex Waldrop, president and CEO of the NTRA.

The entire horse industry, and horse enthusiasts around the world, watched Barbaro's story unfold after his tragic injury during the 2006 Preakness Stakes. Despite the heroic efforts of a team of leading veterinarians at the University of Pennsylvania's New Bolton Center, it was laminitis that finally ended Barbaro's life in January 2007. While Barbaro will always be remembered for his courage -- both on the track and while facing injury -- his owners wanted his legacy to benefit all horses.

"Gretchen and I hope Barbaro's memory can be carried on through advances in medical research, including a cure for laminitis," said Barbaro's owner, Roy Jackson.

More information on Barbaro's legacy, as well as how to get involved with the Barbaro Memorial Fund and make a donation, can be found online at RidingwithBarbaro.org.

Formed in 1999 as a subsidiary of the National Thoroughbred Racing Association (NTRA), NTRA Charities is a nonprofit, 501 (c) (3) public charity. NTRA Charities works to improve the communities that are home to Thoroughbred racing and to ensure the health and safety of the sport's human and equine athletes.

Pfizer, Inc. (NYSE: PFE), the world's largest research-based biomedical and pharmaceutical company, also is a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Animal Health is dedicated to improving the safety, quality and productivity of the world's food supply by enhancing the health of livestock and poultry; and in helping horses and pets to live longer and healthier lives. For additional information on Pfizer's portfolio of equine products, visit http://www.PfizerAH.com.


'/>"/>
SOURCE Pfizer Animal Health
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
2. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
3. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
4. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
5. Kiwa Bio-Tech Animal Feed Volume Increased 25% in Fourth Quarter of 2007
6. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
7. Study Shows Coronado Biosciences Bcl-2 Inhibitor, Apogossypol, is More Efficacious, Less Toxic than Gossypol in Animal Models
8. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
9. Animal Protection Groups Condemn FDAs Endorsement of Animal Cloning
10. Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally
11. Smithfield Foods, Inc. Statement Regarding Animal Cloning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/25/2017)... ... April 25, 2017 , ... As part of the ... explore the laboratory testing for DIC in order to illuminate this clinical problem for ... occur in hospitalized patients resulting in a high degree of morbidity and mortality. DIC ...
(Date:4/25/2017)... ... April 25, 2017 , ... Covalent Metrology has ... Services unit provides high-quality data to clients, both faster and cheaper than ... There are no price premiums, and customers are welcome to participate in the ...
(Date:4/21/2017)... ... ... Having worked on the design of the innovative Triton™ lab bench ... design architects from around the country at the Lab Design Conference 2017 in Raleigh, ... Casey will be at the show, where they will highlight the unique elements of ...
Breaking Biology Technology:
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):